EP3511013
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.8.2011EP published:
7.9.2022EP application number:
18211075.9
EPO information:
European Patent Register
Max expiry date:
22.8.2031
Title in English:
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINESLanguage of the patent:
English
Timeline
Today
23.8.2011EP application
7.9.2022EP Publication
Owner
Name:
University of Pittsburgh - Of the Commonwealth System of Higher EducationAddress:
1st Floor Gardner Steel Conference Center 130 Thackeray Avenue, Pittsburgh, PA 15260, US
Inventor
Name:
Okada, HidehoAddress:
Pittsburgh, PA 15217, US
Priority
Number:
37658210 PDate:
24.8.2010Country:
US
Classification
Categories:
A61K 38/17, A61K 9/00, C07K 14/705, C07K 14/47, A61P 25/00, A61P 43/00, A61K 39/00, C07K 14/715, A61P 35/00, A61P 37/04